|
 |
|
2022 German Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
Highlights - Comprehensive 585-page analysis of the German tumor marker testing market.
- Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....
|
 |
|
$3500.00 |
| |
|
|
|
2022 Japanese Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
Highlights - Comprehensive analysis of the Japanese tumor marker testing market.
- Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....
|
|
|
$3500.00 |
| |
|
|
|
2022 Italian Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
Highlights - Comprehensive 570-page analysis of the Italian tumor marker testing market.
- Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....
|
|
|
$3500.00 |
| |
|
|
|
2022 Spanish Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
Highlights - Comprehensive 565-page analysis of the Spanish tumor marker testing market.
- Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....
|
|
|
$3500.00 |
| |
|
|
|
2022 UK Tumor Marker Testing Market Innovations, Trends and Opportunities for Suppliers
strong>Highlights - Comprehensive 575-page analysis of the UK tumor marker testing market.
- Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....
|
|
|
$3500.00 |
| |
|
|
|
Emerging Strategies for the Global Tumor Marker Testing Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country. The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
|
|
|
$3500.00 |
| |
|
|
|
Tumor Markers: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country. The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
|
|
|
$3500.00 |
| |
|
|
|
Emerging Tumor Markers and Companies Developing Innovative Technologies and Products
Highlights - Comprehensive 260-page market and technological assessment.
- Medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as :
�� - Biochemical Markers
�� - Oncogenes
�� - Growth Factors
�� - Hormones
�� - Colony Stimulating Factors
�� - Lymphokines
�� - Immunohistochemical Stains.
|
|
|
$2850.00 |
| |
|
|
|
Analysis of the US Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including:
|
|
|
$2800.00 |
| |
|
|
|
Leading Tumor Marker Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
This 80-page report presents strategic analyses of major current and emerging suppliers of tumor markers. For each company the report presents: - Sales
- Market shares
- Product portfolios
- Distribution tactics
- Technological know-how
- New products in R&D
- Collaborative arrangements
- Business strategies.
Contains 80 pages
|
|
|
$2500.00 |
| |
|
|
|
Competitive Intelligence: Leading Tumor Marker Diagnostics Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants
This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: - Sales
- Product portfolios
- Distribution tactics
- Technological know-how
- New products in R&D
- Collaborative arrangements
- Business strategies.
Contains 80 pages
|
|
|
$2500.00 |
| |
|
|
|
CompetitiveWatch Tumor Markers: Strategic Assessments of Major Suppliers
This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents.�The assessments include: - Sales
- Product portfolios
- Distribution tactics
- Technological know-how
- New products in R&D
- Collaborative arrangements
- Business strategies.
Contains 80 pages
|
|
|
$2500.00 |
| |
|
|
|
Emerging Opportunities in the Tumor Markers Testing Market: Strategic Assessments of Major Suppliers
This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents.�The assessments include: - Sales
- Product portfolios
- Distribution tactics
- Technological know-how
- New products in R&D
- Collaborative arrangements
- Business strategies.
Contains 80 pages
|
|
|
$2500.00 |
| |
|
|
|
Australia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Austria Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Belgium Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Bulgaria Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Canada Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
|